Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Soliris
Soliris
Alexion Being Probed by HHS Inspector General; Shares Fall
Bloomberg
Thu, 07/6/17 - 06:08 pm
Alexion Pharmaceuticals
HHS
Soliris
fraud
Top 25 rare disease brands, by sales
Medical Marketing and Media
Wed, 02/15/17 - 11:20 am
rare disease
Copaxone
Teva Pharmaceutical
Avonex
Biogen
Sensipar
Soliris
Alexion
Xyrem
Jazz Pharmaceuticals
Alexion Pharmaceuticals says CEO, CFO resign, shares slump
Yahoo/Reuters
Mon, 12/12/16 - 09:37 am
Alexion Pharmaceuticals
Pharma CEOs
Soliris
David Hallal
David Brennan
9 Drugs That Cost Medicare a Fortune
Motley Fool
Sun, 04/10/16 - 01:29 pm
Medicare
Lucentis
Eylea
Prolia
Treanda
Lexiscan
Yervoy
Privigen
Provenge
Soliris
Will Soliris’s Label Expansion Fuel Alexion’s Growth?
Yahoo/Market Realist
Thu, 03/3/16 - 10:43 am
Alexion
Soliris
aHUS
Alexion's Soliris, Bayer's Xarelto get stiff-armed by a couple of cost gatekeepers
Fierce Pharma
Wed, 02/17/16 - 09:44 pm
Alexion
Soliris
Bayer
Xarelto
UK
Canada
New Zealand
The 'Soliris-killer' cometh? Alnylam plans final 2017 trials to take on world's priciest drug
BioPharma Dive
Fri, 12/11/15 - 10:58 am
Soliris
Alnylam
Alexion
PNH
Alnylam Going After World's Most Expensive Drug in New Trials
Bloomberg
Thu, 12/10/15 - 10:29 am
Alnylam
ALN-CC5
Soliris
PNH
This Drugmaker's Incredible Run Looks Far From Done
Motley Fool
Wed, 08/19/15 - 09:22 am
Alexion
aHUS
Soliris
Omeros Corporation: Another Biotech Bubble In The Making?
Yahoo/Benzinga
Wed, 08/19/15 - 09:26 am
Omeros
OMS721
Soliris
aHUS
The 5 Most Expensive Drugs in the World in 2015
Motley Fool
Sun, 08/16/15 - 10:32 am
drug pricing
Glybera
Soliris
Naglazyme
Vimizim
Elaprase
Shire
Biomarin
Alexion
uniQure
Big Pharmas back Ra's $58.5M bet on a rival to Soliris
Fierce Biotech
Thu, 07/23/15 - 12:05 pm
Ra Pharmaceuticals
Alexion
Soliris
C5 inhibitor
RA101495
Analyst: Alexion Pharmaceuticals Pipeline Is Undervalued
Yahoo/Benzinga
Thu, 03/12/15 - 11:05 am
Alexion
AXLN1007
Soliris
Alexion Pharmaceuticals Proves That Soliris Isn't Immune To Failure
Seeking Alpha
Tue, 01/20/15 - 09:26 am
Alexion
Soliris
orphan drugs
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Politicians Shouldn't Question Drug Costs But Rather Their Value. Lessons From Soliris And Sovaldi.
Forbes
Mon, 08/4/14 - 09:37 am
Sovaldi
Soliris
R&D
Alexion Pharma Looks To Life Beyond Its Blockbuster
Investors.com
Tue, 07/8/14 - 04:52 pm
Alexion
Soliris
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
Thu, 07/3/14 - 12:07 pm
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
Alexion to book additional Soliris sales, raises outlook
Reuters
Mon, 03/10/14 - 08:37 am
Alexion
Soliris
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »